Breast Cancer in Pregnancy

Document Type : Review Article

Authors

1 Department of Midwifery, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran

2 Associate Professor, Department of Radiation Oncology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Professor, Department of Radiation Oncology, Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Abstract

Malignant neoplasms are the second most common cause of death in women during childbearing age; however, the occurrence of cancer during pregnancy is rare and only 0.02-0.1 percent of all pregnancies is associated with cancer. By increasing the rate of pregnancies in older ages, the incidence of cancer during pregnancy is also being increased. Breast cancer is the second most frequent cancer presenting during pregnancy. Pregnancy-associated breast cancer is defined as breast cancer that is diagnosed during pregnancy, lactation in or at the first postpartum year. Physiologic changes related to the pregnancy and the fetus are the most important diagnostic and therapeutic challenges in pregnant women. The signs and the symptoms of the pregnancy can mask breast cancer in a pregnant woman and lead to late cancer diagnosis. In addition, concerning fetus safety, there are many limitations and contraindications for using diagnostic and therapeutic methods during pregnancy. Due to the absence of major cohort srudies and large randomized trials, many questions regarding the consequences of the diagnosis and treatment of breast cancer in pregnancy remain unanswered. In this article, we review the most important diagnostic and therapeutic challenges and approaches in this group of patients.

Keywords

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61(2): 69-90.
  2. Salani R, Billingsley CC, Crafton SM. Cancer and pregnancy: an overview for obstetricians and gynecologists. Am J Obstet Gynecol 2014; 211(1): 7-14.
  3. Johansson AL, Andersson TM, Hsieh CC, Jirstrom K, Dickman P, Cnattingius S, et al. Stage at diagnosis and mortality in women with pregnancy-associated breast cancer (PABC). Breast Cancer Res Treat 2013; 139(1): 183-92.
  4. Pavlidis N. Cancer and pregnancy: what should we know about the management with systemic treatment of pregnant women with cancer? Eur J Cancer 2011; 47(Suppl 3): S348-S352.
  5. Rovera F, Frattini F, Coglitore A, Marelli M, Rausei S, Dionigi G, et al. Breast cancer in pregnancy. Breast J 2010; 16(Suppl 1): S22-S25.
  6. Partridge A, Schapira L. Pregnancy and breast cancer: epidemiology, treatment, and safety issues. Oncology (Williston Park) 2005; 19(6): 693-7.
  7. Ring AE, Smith IE, Ellis PA. Breast cancer and pregnancy. Ann Oncol 2005; 16(12): 1855-60.
  8. Omidvari Sh, Hosseini S, Ashouri Y, Tahmasebi S, Talei A, Nasrolahi H, et al. Comparison of docetaxel, doxorubicin and cyclophosphamide (TAC) with 5-fluorouracil, doxorubicin and cyclophosphamide (FAC) neoadjuvant chemotherapy in locally advanced breast cancer: A phase III clinical trial. Middle East J Cancer 2011; 2(2): 51-8.
  9. Mosalaei A, Mohammadianpanah M, Omidvari S, Ahmadloo N. High-dose rate brachytherapy in the treatment of carcinoma of uterine cervix: twenty-year experience with cobalt after-loading system. Int J Gynecol Cancer 2006; 16(3): 1101-5.
  10. Namazi S, Daneshian A, Mohammadianpanah M, Jafari P, Ardeshir-Rouhani-Fard S, Nasirabadi S. The impact of renin-angiotensin system, angiotensin capital I, Ukrainian converting enzyme (insertion/deletion), and angiotensin capital I, Ukrainiancapital I, Ukrainian type 1 receptor (A1166C) polymorphisms on breast cancer survival in Iran. Gene 2013; 532(1): 125-31.
  11. Janni W, Rack B, Gerber B, Bauerfeind I, Krause A, Dian D, et al. Pregnancy-associated breast cancer -- special features in diagnosis and treatment. Onkologie 2006; 29(3): 107-12.
  12. Baysinger CL. Imaging during pregnancy. Anesth Analg 2010; 110(3): 863-7.
  13. Vashi R, Hooley R, Butler R, Geisel J, Philpotts L. Breast imaging of the pregnant and lactating patient: imaging modalities and pregnancy-associated breast cancer. AJR Am J Roentgenol 2013; 200(2): 321-8.
  14. Son EJ, Oh KK, Kim EK. Pregnancy-associated breast disease: radiologic features and diagnostic dilemmas. Yonsei Med J 2006; 47(1): 34-42.
  15. Rosenkranz KM, Lucci A. Surgical treatment of pregnancy associated breast cancer. Breast Dis 2005; 23: 87-93.
  16. Pereg D, Koren G, Lishner M. Cancer in pregnancy: gaps, challenges and solutions. Cancer Treat Rev 2008; 34(4): 302-12.
  17. Zagouri F, Psaltopoulou T, Dimitrakakis C, Bartsch R, Dimopoulos MA. Challenges in managing breast cancer during pregnancy. J Thorac Dis 2013; 5(Suppl 1): S62-S67.
  18. Schotte K, Cocquyt V, Van den Broecke R, Dhondt M, Van Belle S. Breast cancer during pregnancy: cases and review of treatment and prognosis. Acta Clin Belg 2000; 55(2): 102-9.
  19. Pilewskie M, Gorodinsky P, Fought A, Hansen N, Bethke K, Jeruss J, et al. Association between recency of last pregnancy and biologic subtype of breast cancer. Ann Surg Oncol 2012; 19(4): 1167-73.
  20. Asgeirsson KS. Pregnancy-associated breast cancer. Acta Obstet Gynecol Scand 2011; 90(2): 158-66.
  21. Pentheroudakis G, Pavlidis N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer 2006; 42(2): 126-40.
  22. Toosi M, Moaddabshoar L, Malek-Hosseini SA, Sasani MR, Mokhtari M, Mohammadianpanah M. Rectal cancer in pregnancy: a diagnostic and therapeutic challenge. J Egypt Natl Canc Inst 2014; 26(3): 175-9.
  23. Sukumvanich P. Review of current treatment options for pregnancy-associated breast cancer. Clin Obstet Gynecol 2011; 54(1): 164-72.
  24. Martin DD. Review of radiation therapy in the pregnant cancer patient. Clin Obstet Gynecol 2011; 54(4): 591-601.
  25. Amant F, Loibl S, Neven P, Van Calsteren K. Breast cancer in pregnancy. Lancet 2012; 379(9815): 570-9.
  26. Ansari M, Farzin D, Mosalaei A, Omidvari S, Ahmadloo N, Mohammadianpanah M. Efficacy of topical alpha ointment (containing natural henna) compared to topical hydrocortisone (1%) in the healing of radiation-induced dermatitis in patients with breast cancer: a randomized controlled clinical trial. Iran J Med Sci 2013; 38(4): 293-300.
  27. Mohammadianpanah M, Ashouri Y, Hoseini S, Amadloo N, Talei A, Tahmasebi S, et al. The efficacy and safety of neoadjuvant chemotherapy +/- letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial. Breast Cancer Res Treat 2012; 132(3): 853-61.
  28. Ahmadloo N, Nazer Mozaffari M, Mohammadianpanah M, Omidvari S, Mosalaei A, Mosleh Shirazi M. Combined neoadjuvant chemotherapy and celecoxib in locally advanced breast cancer. Iran Red Crescent Med J 2009; 11(4): 419-24.
  29. Cardonick E, Dougherty R, Grana G, Gilmandyar D, Ghaffar S, Usmani A. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J 2010; 16(1): 76-82.
  30. Koren G, Carey N, Gagnon R, Maxwell C, Nulman I, Senikas V. Cancer chemotherapy and pregnancy. J Obstet Gynaecol Can 2013; 35(3): 263-80.
  31. McGrath SE, Ring A. Chemotherapy for breast cancer in pregnancy: evidence and guidance for oncologists. Ther Adv Med Oncol 2011; 3(2): 73-83.
  32. Peres RM, Sanseverino MT, Guimaraes JL, Coser V, Giuliani L, Moreira RK, et al. Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: a multicenter study. Braz J Med Biol Res 2001; 34(12): 1551-9.
  33. Loibl S, von MG, Gwyn K, Ellis P, Blohmer JU, Schlegelberger B, et al. Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 2006; 106(2): 237-46.
  34. Ali SA, Gupta S, Sehgal R, Vogel V. Survival outcomes in pregnancy associated breast cancer: a retrospective case control study. Breast J 2012; 18(2): 139-44.
  35. Fernandes AF, Santos MC, de Castro e Silva TB, Galvao CM. Prognosis of breast cancer during pregnancy: evidence for nursing care. Rev Lat Am Enfermagem 2011; 19(6): 1453-61.
  36. Stensheim H, Moller B, van Dijk T, Fossa SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 2009; 27(1): 45-51.
  37. Helewa M, Levesque P, Provencher D, Lea RH, Rosolowich V, Shapiro HM. Breast cancer, pregnancy, and breastfeeding. J Obstet Gynaecol Can 2002; 24(2): 164-80.
  38. Matthews ML, Hurst BS, Marshburn PB, Usadi RS, Papadakis MA, Sarantou T. Cancer, fertility preservation, and future pregnancy: a comprehensive review. Obstet Gynecol Int 2012; 2012: 953937.
  39. Gurgan T, Salman C, Demirol A. Pregnancy and assisted reproduction techniques in men and women after cancer treatment. Placenta 2008; 29(Suppl B): 152-9.
  40. Perez-Fidalgo JA, Rosello S, Garcia-Garre E, Jorda E, Martin-Martorell P, Bermejo B, et al. Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens. Breast Cancer Res Treat 2010; 120(1): 245-51.
  41. Pagani O, Partridge A, Korde L, Badve S, Bartlett J, Albain K, et al. Pregnancy after breast cancer: if you wish, ma'am. Breast Cancer Res Treat 2011; 129(2): 309-17.
Journal of Isfahan Medical School
Volume 33, Issue 347 - Serial Number 347
July and August 2015
Pages 1380-1390

Files

History

  • Receive Date: 02 June 2014
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics